What is the recommended management for a Mallory‑Weiss tear?

Management of Mallory-Weiss Tear

Most Mallory-Weiss tears are self-limiting and require only supportive care with hemodynamic stabilization; patients with low-risk endoscopic findings (no active bleeding, no visible vessel) can be fed immediately and discharged after stabilization. 1

Initial Assessment and Risk Stratification

The management approach depends entirely on the endoscopic appearance at the time of diagnosis:

Low-Risk Features (No Intervention Needed)

• Tears without active bleeding and no visible vessel require no endoscopic therapy due to the self-limiting nature in most cases 2, 3
• These patients can be fed within 24 hours and discharged home immediately after hemodynamic stabilization 1
• The overall in-hospital mortality is low at 2.7%, with most cases resolving spontaneously 2

High-Risk Features (Endoscopic Intervention Required)

Endoscopic hemostasis is indicated when you observe:

• Active bleeding at the time of endoscopy 3, 4
• Visible vessel present in the tear 4
• Stigmata of recent bleeding 5

Endoscopic Treatment Options

When intervention is necessary, multiple effective modalities exist:

First-Line Endoscopic Therapies

Endoscopic band ligation appears to be the most efficient procedure for achieving primary hemostasis and preventing rebleeding 5, though several alternatives are equally effective:

• Hemoclipping: Most commonly used in recent practice (used in 12.8% of cases), particularly effective and widely available 2, 4
• Injection therapy: Most frequently performed overall (13.7% of cases), includes epinephrine injection as effective first-line therapy 2, 3
• Multipolar electrocoagulation (MPEC): Has the best evidence-based support for safety and bleeding control, though avoid if esophageal varices are suspected 4
• Argon plasma coagulation: Alternative thermal method 3

Combination Therapy

• Combination of injection plus clipping is commonly used for more severe bleeding 2
• Selection depends on the endoscopist's experience and the clinical scenario 3, 4

Special Considerations for Specific Techniques

Avoid multipolar electrocoagulation if varices are suspected, as it may precipitate or aggravate bleeding 4

Avoid epinephrine injection in patients with coronary artery disease due to potential systemic absorption 4

Adjunctive Medical Therapy

Proton Pump Inhibitors

• Administer proton pump inhibitors to all patients, though definitive evidence specific to Mallory-Weiss tears is limited 1, 5
• High-dose regimens (omeprazole 40 mg every 12 hours for 5 days) have shown decreased rebleeding in upper GI bleeding studies 1
• The route (IV vs oral) can be tailored: IV for high-risk patients, oral for low-risk patients 1

Antiemetics

• Use of antiemetics is logical to prevent further retching and vomiting, though evidence is limited 5

Refractory Cases

Surgical intervention is rarely needed (only 0.1% of cases) 2

If bleeding continues or recurs despite endoscopic therapy:

• Refer for surgical treatment if the patient is a surgical candidate 4
• For non-surgical candidates, interventional radiology with selective vasopressin or Gelfoam embolization is a viable alternative 4

Prognostic Factors

Be aware of complications associated with significantly worse prognosis 2:

• Hypovolemic shock (present in 2.9% of cases)
• Acute kidney injury
• Sepsis
• Need for artificial ventilation
• Adult respiratory distress syndrome
• Bleeding anemia (present in 26% of cases)
• Female sex

Common Clinical Pitfalls

• Do not assume antecedent vomiting or retching: 41% of patients have no preceding nausea, retching, or vomiting 6
• Inspect the stomach during and after any upper endoscopy procedure to detect iatrogenic tears, particularly in elderly patients or those with prior distal gastrectomy 7, 8
• Multiple bleeding episodes occur in 12% of cases, so appropriate monitoring is essential 6